28.8 C
Vientiane
Friday, July 11, 2025
spot_img

Cision PR Newswire

Manhattan Associates Transforms Enterprise Selling with Enterprise Promise & Fulfill™

New B2B sales and fulfilment solution adds new selling and fulfilment capabilities to existing ERP environments, elevating sales revenues, improving inventory accuracy and performance, and enhancing customer experiences SYDNEY, June 4, 2025 /PRNewswire/ -- Manhattan Associates Inc. (NASDAQ: MANH), the global leader in supply chain commerce solutions,...

Kiwa PVEL Releases 11th Edition of the PV Module Reliability Scorecard

The total number of Top Performers remains steady, but failures have increased NAPA, Calif., June...

Asia Pacific Enterprise Awards (APEA) 2025 Malaysia Celebrates Future-Ready Enterprises Driving the Nation’s Growth

KUALA LUMPUR, Malaysia, June 4, 2025 /PRNewswire/ -- The Asia Pacific Enterprise Awards (APEA)...

AXA Launches “Max Goal II Insurance Plan”

Shortest guaranteed breakeven timeframe and market-first Wealth Master Service to empower High-Net-Worth Individuals to secure...

Witness the power of images to change the world: The First SmallRig Awards Announce 22 Global Winners

SHENZHEN, China, June 4, 2025 /PRNewswire/ -- The 2025 International Image Culture Week kicked...

Lake Resources Announces Exploration of Strategic Alternatives

SYDNEY, May 7, 2025 /PRNewswire/ -- Lake Resources N.L. (ASX: LKE; OTC: LLKKF) ("Lake" or the "Company"), a responsible lithium developer, announced today that...

FancyTech Closes Series B+ to Power AI Personalized Content Solutions in Thailand and Southeast Asia

BANGKOK, May 7, 2025 /PRNewswire/ -- FancyTech, an AI startup specializing in commercial content generation and winner of the 2024 LVMH Innovation Award,...

Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific...

SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures...

CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR

SUZHOU, China, May 7, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations...